Literature DB >> 33766082

Prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with diabetes and clinical atherosclerotic cardiovascular diseases: a cross-sectional study.

Teeraboon Lertwanichwattana1, Ram Rangsin1, Boonsub Sakboonyarat2.   

Abstract

OBJECTIVES: The research aimed to determine the prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with the disease and Clinical ASCVD.
RESULTS: A total of 1,527 Thai diabetic patients with a history of ASCVD were included in the study. Uncontrolled hyperlipidemia was detected among 1,216 patients (79.6%; 95% CI 77.6-81.7). The independent factors associated with uncontrolled hyperlipidemia included being female (adjusted odds ratio (AORs); 1.5, 95% CI 1.2-2.0), using thiazolidinedione (AORs; 1.7, 95% CI 1.1-2.7), community hospital (AORs; 4.3, 95% CI 1.0-18.0) and BMI level at 18.5-22.9 kg/m2 (AORs; 2.2, 95% CI 1.2-4.0), 23.0-24.9 kg/m2 (AORs; 1.8 95% CI 0.9-3.3), 25.0-29.9 kg/m2 (AORs; 2.3 95% CI 1.3-4.3) and ≥ 30 kg/m2 (AORs; 2.5 95% CI 1.3-4.9).

Entities:  

Keywords:  ASCVD; Diabetes; Prevalence; Risk factors; Uncontrolled hyperlipidemia

Mesh:

Year:  2021        PMID: 33766082      PMCID: PMC7993520          DOI: 10.1186/s13104-021-05535-6

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  37 in total

Review 1.  8. Cardiovascular Disease and Risk Management.

Authors: 
Journal:  Diabetes Care       Date:  2016-01       Impact factor: 19.112

2.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  J Am Coll Cardiol       Date:  2018-11-10       Impact factor: 24.094

Review 3.  Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists.

Authors:  Haywood L Brown; John J Warner; Eugenia Gianos; Martha Gulati; Alexandria J Hill; Lisa M Hollier; Stacey E Rosen; Mary L Rosser; Nanette K Wenger
Journal:  Circulation       Date:  2018-05-10       Impact factor: 29.690

4.  Hormone-sensitive lipase is required for high-density lipoprotein cholesteryl ester-supported adrenal steroidogenesis.

Authors:  Fredric B Kraemer; Wen-Jun Shen; Kenji Harada; Shailja Patel; Jun-ichi Osuga; Shun Ishibashi; Salman Azhar
Journal:  Mol Endocrinol       Date:  2003-12-04

Review 5.  Lipoprotein lipase in diabetes.

Authors:  M R Taskinen
Journal:  Diabetes Metab Rev       Date:  1987-04

6.  Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; David C Goff; Donald M Lloyd-Jones; Sidney C Smith; Conrad Blum; J Sanford Schwartz
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

Review 7.  Diabetic dyslipidemia.

Authors:  Liya Wu; Klaus G Parhofer
Journal:  Metabolism       Date:  2014-08-29       Impact factor: 8.694

8.  Correlation between Body Mass Index and Lipid Profile in patients with Type 2 Diabetes attending a tertiary care hospital in Peshawar.

Authors:  Arshad Hussain; Iftikhar Ali; Waqar Ahmad Kaleem; Fatima Yasmeen
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

9.  Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.

Authors:  Ploypun Narindrarangkura; William Bosl; Ram Rangsin; Panadda Hatthachote
Journal:  Lipids Health Dis       Date:  2019-04-06       Impact factor: 3.876

Review 10.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.